Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × ponatinib × Clear all

NCT03704688 2025-05-16

Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

12 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung